We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Arctoris Ltd Moves Global Headquarters to Oxford, UK

Arctoris Ltd Moves Global Headquarters to Oxford, UK content piece image
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Arctoris Ltd, the developer of the world’s first fully automated drug discovery platform, has opened the doors to its new global headquarters and state-of-the-art research and development (R&D) facility in Oxford, UK. Housing the company’s proprietary technology and providing space for its rapidly growing commercial and scientific teams, the facility is designed to enable Arctoris to continue to support its research partners around the world with its structured, automated approach to drug discovery.

At the heart of the new scientific facility is the next-generation, fully automated platform developed by the drug discovery experts, engineers and roboticists at Arctoris. The platform generates reproducible data from biochemical, cell-based and molecular biology assays.

The rapid turnaround enables shorter cycle times – and therefore more design-make-test analyze iterations – for their drug discovery partners. This end-to-end robotic platform aims to provide biotechnology companies, pharmaceutical corporations and academic centers with cost effective and reproducible drug discovery data – all through an online portal that streamlines experiment planning, ordering, tracking and data analysis.